These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35041178)

  • 21. Monomethyl fumarate has better gastrointestinal tolerability profile compared with dimethyl fumarate.
    Wynn D; Lategan TW; Sprague TN; Rousseau FS; Fox EJ
    Mult Scler Relat Disord; 2020 Oct; 45():102335. PubMed ID: 32629403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monomethyl Fumarate (MMF, Bafiertam) for the Treatment of Relapsing Forms of Multiple Sclerosis (MS).
    Berger AA; Sottosanti ER; Winnick A; Izygon J; Berardino K; Cornett EM; Kaye AD; Varrassi G; Viswanath O; Urits I
    Neurol Int; 2021 May; 13(2):207-223. PubMed ID: 34069538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioanalysis of monomethyl fumarate in human plasma by a sensitive and rapid LC-MS/MS method and its pharmacokinetic application.
    S IP; Varanasi MB; Mohammed I
    J Pharm Biomed Anal; 2017 Nov; 146():109-116. PubMed ID: 28873360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics of mycophenolic acid : a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients.
    de Winter BC; van Gelder T; Glander P; Cattaneo D; Tedesco-Silva H; Neumann I; Hilbrands L; van Hest RM; Pescovitz MD; Budde K; Mathot RA
    Clin Pharmacokinet; 2008; 47(12):827-38. PubMed ID: 19026038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effects of monomethyl fumarate at the inflamed blood-brain barrier.
    Lim JL; van der Pol SM; Di Dio F; van Het Hof B; Kooij G; de Vries HE; van Horssen J
    Microvasc Res; 2016 May; 105():61-9. PubMed ID: 26679389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dimethyl fumarate downregulates the immune response through the HCA
    von Glehn F; Dias-Carneiro RPC; Moraes AS; Farias AS; Silva VAPG; Oliveira FTM; Silva CEBG; de Carvalho F; Rahal E; Baecher-Allan C; Santos LMB
    Mult Scler Relat Disord; 2018 Jul; 23():46-50. PubMed ID: 29763776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dimethyl fumarate transfer into human milk.
    Ciplea AI; Datta P; Rewers-Felkins K; Baker T; Gold R; Hale TW; Hellwig K
    Ther Adv Neurol Disord; 2020; 13():1756286420968414. PubMed ID: 33193814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fumarate decreases edema volume and improves functional outcome after experimental stroke.
    Clausen BH; Lundberg L; Yli-Karjanmaa M; Martin NA; Svensson M; Alfsen MZ; Flæng SB; Lyngsø K; Boza-Serrano A; Nielsen HH; Hansen PB; Finsen B; Deierborg T; Illes Z; Lambertsen KL
    Exp Neurol; 2017 Sep; 295():144-154. PubMed ID: 28602832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population Pharmacokinetics of Daclizumab High-Yield Process in Healthy Volunteers and Subjects with Multiple Sclerosis: Analysis of Phase I-III Clinical Trials.
    Diao L; Hang Y; Othman AA; Nestorov I; Tran JQ
    Clin Pharmacokinet; 2016 Aug; 55(8):943-55. PubMed ID: 26873229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice.
    Yao Y; Miao W; Liu Z; Han W; Shi K; Shen Y; Li H; Liu Q; Fu Y; Huang D; Shi FD
    Transl Stroke Res; 2016 Dec; 7(6):535-547. PubMed ID: 27614618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of tapentadol immediate release (IR) in healthy subjects and patients with moderate or severe pain.
    Xu XS; Smit JW; Lin R; Stuyckens K; Terlinden R; Nandy P
    Clin Pharmacokinet; 2010 Oct; 49(10):671-82. PubMed ID: 20818833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dimethyl fumarate and monomethyl fumarate attenuate oxidative stress and mitochondrial alterations leading to oxiapoptophagy in 158N murine oligodendrocytes treated with 7β-hydroxycholesterol.
    Sghaier R; Nury T; Leoni V; Caccia C; Pais De Barros JP; Cherif A; Vejux A; Moreau T; Limem K; Samadi M; Mackrill JJ; Masmoudi AS; Lizard G; Zarrouk A
    J Steroid Biochem Mol Biol; 2019 Nov; 194():105432. PubMed ID: 31344443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pharmacokinetic and biomarker study of delayed-release dimethyl fumarate in subjects with secondary progressive multiple sclerosis: evaluation of cerebrospinal fluid penetration and the effects on exploratory biomarkers.
    Edwards KR; Kamath A; Button J; Kamath V; Mendoza JP; Zhu B; Plavina T; Woodward C; Penner N
    Mult Scler Relat Disord; 2021 Jun; 51():102861. PubMed ID: 33773271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.
    Booth L; Cruickshanks N; Tavallai S; Roberts JL; Peery M; Poklepovic A; Dent P
    Cancer Biol Ther; 2014; 15(12):1646-57. PubMed ID: 25482938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxycarboxylic Acid Receptor 2, a Pleiotropically Linked Receptor for the Multiple Sclerosis Drug, Monomethyl Fumarate. Possible Implications for the Inflammatory Response.
    Parodi B; Sanna A; Cedola A; Uccelli A; Kerlero de Rosbo N
    Front Immunol; 2021; 12():655212. PubMed ID: 34084164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects.
    Tan B; Naik H; Jang IJ; Yu KS; Kirsch LE; Shin CS; Craft JC; Fleckenstein L
    Malar J; 2009 Dec; 8():304. PubMed ID: 20021657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and food interaction of a novel prodrug of tenofovir, tenofovir dipivoxil fumarate, in healthy volunteers.
    Lu C; Jia Y; Chen L; Ding Y; Yang J; Chen M; Song Y; Sun X; Wen A
    J Clin Pharm Ther; 2013 Apr; 38(2):136-40. PubMed ID: 23278367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers.
    Waitzinger J; Bepperling F; Pabst G; Opitz J; Müller M; François Baron J
    Clin Drug Investig; 1998; 16(2):151-60. PubMed ID: 18370533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
    Kourakis S; Timpani CA; de Haan JB; Gueven N; Fischer D; Rybalka E
    Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33066228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetics of losmapimod in healthy subjects and patients with rheumatoid arthritis and chronic obstructive pulmonary diseases.
    Yang S; Lukey P; Beerahee M; Hoke F
    Clin Pharmacokinet; 2013 Mar; 52(3):187-98. PubMed ID: 23254770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.